These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 418906)

  • 1. [Preparation and experimental antitumor activity of a new semi-synthetic antibiotic: 14-diethoxyacetoxy daunorubicin (R.P. 33 921)].
    Maral R; Ducep JB; Farge D; Ponsinet G; Reisdorf D
    C R Acad Hebd Seances Acad Sci D; 1978 Feb; 286(5):443-6. PubMed ID: 418906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological activities of rubidazone.
    Maral R
    Cancer Chemother Pharmacol; 1979; 2(1):31-5. PubMed ID: 498417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adriamycin analogues. Novel anomeric ribofuranoside analogues of daunorubicin.
    Israel M; Airey JE; Murray RJ; Gillard JW
    J Med Chem; 1982 Jan; 25(1):28-31. PubMed ID: 7086818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syntheses and antitumor activities of 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
    Tsuchiya T; Takagi Y; Ok K; Umezawa S; Takeuchi T; Wako N; Umezawa H
    J Antibiot (Tokyo); 1986 May; 39(5):731-3. PubMed ID: 3733524
    [No Abstract]   [Full Text] [Related]  

  • 5. Antitumor antibiotic carminomycin.
    Gause GF
    Z Allg Mikrobiol; 1980; 20(3):219-25. PubMed ID: 6158803
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutagenic and cytotoxic activity of doxorubicin and daunorubicin derivatives on prokaryotic and eukaryotic cells.
    Babudri N; Pani B; Tamaro M; Monti-Bragadin C; Zunino F
    Br J Cancer; 1984 Jul; 50(1):91-6. PubMed ID: 6378238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adriamycin analogues. Preparation and biological evaluation of some N-perfluoroacyl analogues of daunorubicin, adriamycin, and N-(trifluoroacetyl)adriamycin 14-valerate and their 9,10-anhydro derivatives.
    Israel M; Potti G
    J Med Chem; 1982 Feb; 25(2):187-91. PubMed ID: 7057426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3'-Deamino-4'-epi-3'-hydroxy-daunorubicin and -doxorubicin. Synthesis and antitumor activity.
    Horton D; Priebe W; Varela O
    J Antibiot (Tokyo); 1984 Dec; 37(12):1635-41. PubMed ID: 6549317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antitumor activity of 4'-O-methyldaunorubicin, 4'-O-methyladriamycin, and their 4'-epi analogues.
    Cassinelli G; Ruggieri D; Arcamone F
    J Med Chem; 1979 Feb; 22(2):121-3. PubMed ID: 423191
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and antileukemic activity of N-enamine derivatives of daunorubicin, 5-iminodaunorubicin, and doxorubicin.
    Stefańska B; Dzieduszycka M; Bontemps-Gracz M; Borowski E; Martelli S
    J Antibiot (Tokyo); 1988 Feb; 41(2):193-8. PubMed ID: 3356607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrahydropyranyl derivatives of daunomycin and adriamycin.
    Umezawa H; Takahashi Y; Kinoshita M; Naganawa H; Masuda T; Ishizuka M; Tatsuta K; Takeuchi T
    J Antibiot (Tokyo); 1979 Oct; 32(10):1082-4. PubMed ID: 528373
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental and clinical activity of a new anthracycline derivative: detorubicin (14-diethoxyacetoxydaunorubicin).
    Maral R; Heusse D; Lavelle F; Cueille G; Marlard M; Jacquillat C; Maral J; Auclerc MF; Weil M; Auclerc G; Bernard J
    Recent Results Cancer Res; 1980; 74():172-83. PubMed ID: 7444138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
    Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel peptide conjugates for tumor-specific chemotherapy.
    Langer M; Kratz F; Rothen-Rutishauser B; Wunderli-Allenspach H; Beck-Sickinger AG
    J Med Chem; 2001 Apr; 44(9):1341-8. PubMed ID: 11311056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Iminodaunorubicin. Reduced cardiotoxic properties in an antitumor anthracycline.
    Tong GL; Henry DW; Acton EM
    J Med Chem; 1979 Jan; 22(1):36-9. PubMed ID: 423181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA complexing antibiotics: daunomycin, adriamycin and their derivatives.
    Marco A; Arcamone F
    Arzneimittelforschung; 1975 Mar; 25(3):368-74. PubMed ID: 1174034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the structure of new anthracycline antibiotics on their biological properties.
    Wasowska M; Oszczapowicz I; Wietrzyk J; Opolski A; Madej J; Dzimira S; Oszczapowicz J
    Anticancer Res; 2005; 25(3B):2043-8. PubMed ID: 16158943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of new N-substituted daunorubicin derivatives.
    Mazerska Z; Woynarowska B; Stefanska B; Borowski E; Martelli S
    Drugs Exp Clin Res; 1987; 13(6):345-51. PubMed ID: 3308387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New antitumor anthracyclines.
    Arcamone F
    Lloydia; 1977; 40(1):45-66. PubMed ID: 875639
    [No Abstract]   [Full Text] [Related]  

  • 20. 4-Demethoxy-4-hydroxydaunorubicin 6-methyl ether and 11-methyl ether, two active isomers of daunorubicin.
    Masi P; Suarato A; Giardino P; Iraci G; Bernardi L; Arcamone F
    Farmaco Sci; 1980 May; 35(5):347-56. PubMed ID: 7450036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.